APRINOIA Therapeutics Inc. (APRI)

APRINOIA Therapeutics was planning to go public, but the IPO was withdrawn on Oct 28, 2024.

IPO Price Range

$10.00 - $12.00

Shares Offered

500,000

Deal Size

$5.50M

APRINOIA Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	295	-	-
Enterprise Value	303	-	-
Debt / Equity Ratio	-0.19	-0.05	-0.02
Debt / EBITDA Ratio	-0.79	-0.13	-0.05
Debt / FCF Ratio	-1.10	-0.19	-0.04
Quick Ratio	0.27	0.08	2.25
Interest Coverage	-13.47	-420.10	-645.14
Return on Equity (ROE)	26.71%	37.42%	47.78%
Return on Assets (ROA)	-	-500.28%	-182.21%
Return on Capital (ROIC)	32.16%	39.34%	50.23%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).